135 related articles for article (PubMed ID: 37790828)
1. Analysis of Terminated Hand and Wrist-Related Clinical Trials.
Delma S; Foster BK; Baylor JL; Ozdag Y; Manzar S; Langford K; Klena JC; Grandizio LC
J Hand Surg Glob Online; 2023 Sep; 5(5):673-676. PubMed ID: 37790828
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the frequency, characteristics, and reasons for termination of shoulder- and elbow-related clinical trials.
Caruana DL; Gouzoulis MJ; McLaughlin WM; Grauer JN
J Shoulder Elbow Surg; 2022 Sep; 31(9):1922-1928. PubMed ID: 35398166
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Frequency, Characteristics, and Reasons for Termination of Spine-related Clinical Trials.
Caruana DL; Nam-Woo Kim D; Galivanche AR; David WB; Justen MA; Moushey AM; Sheth AH; Paranjpe MD; Grauer JN
Clin Spine Surg; 2022 Aug; 35(7):E596-E600. PubMed ID: 35351841
[TBL] [Abstract][Full Text] [Related]
4. Analysis of factors leading to early termination in glioblastoma-related clinical trials.
Shah HA; Mishra A; Gouzoulis MJ; Ben-Shalom N; D'Amico RS
J Neurooncol; 2022 Jul; 158(3):489-495. PubMed ID: 35648307
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Terminated Trials in the ClinicalTrials.gov Results Database: Evaluation of Availability of Primary Outcome Data and Reasons for Termination.
Williams RJ; Tse T; DiPiazza K; Zarin DA
PLoS One; 2015; 10(5):e0127242. PubMed ID: 26011295
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, characteristics, and predictors of early termination of cardiovascular clinical trials due to low recruitment: insights from the ClinicalTrials.gov registry.
Bernardez-Pereira S; Lopes RD; Carrion MJ; Santucci EV; Soares RM; de Oliveira Abreu M; Laranjeira LN; Ikeoka DT; Zazula AD; Moreira FR; Cavalcanti AB; Mesquita ET; Peterson ED; Califf RM; Berwanger O;
Am Heart J; 2014 Aug; 168(2):213-9.e1. PubMed ID: 25066561
[TBL] [Abstract][Full Text] [Related]
8. Unfinished business: Terminated cancer trials and the relevance of treatment intent, sponsors and intervention types.
Buergy D; Riedel J; Sarria GR; Ehmann M; Scafa D; Grilli M; Wenz F; Hofheinz RD
Int J Cancer; 2021 Apr; 148(7):1676-1684. PubMed ID: 33045097
[TBL] [Abstract][Full Text] [Related]
9. Premature Clinical Trial Discontinuation in the Era of Immune Checkpoint Inhibitors.
Khunger M; Rakshit S; Hernandez AV; Pasupuleti V; Glass K; Galsky MD; Grivas P
Oncologist; 2018 Dec; 23(12):1494-1499. PubMed ID: 30068783
[TBL] [Abstract][Full Text] [Related]
10. Reasons for and associated characteristics with early study termination: Analysis of ClinicalTrials.gov data on pregnancy topics.
Shieh C; Ofner S; Draucker CB
Nurs Outlook; 2022; 70(2):271-279. PubMed ID: 35090741
[TBL] [Abstract][Full Text] [Related]
11. Assessing clinical trial failure risk factors and reasons in gastric cancer.
Zhang Z; Yin J; Yue Y; Su Y; Jiang H
BMC Gastroenterol; 2022 Nov; 22(1):496. PubMed ID: 36451088
[TBL] [Abstract][Full Text] [Related]
12. The impact of the COVID-19 pandemic on early termination of ophthalmology clinical trials: A cross-sectional analysis of ClinicalTrials.gov.
Kakkilaya A; Hooda K; Kalva P; Dasara H; Janssen C; Vasireddy S; Ahmed A; Khan S; Kooner K
SAGE Open Med; 2023; 11():20503121231216592. PubMed ID: 38078203
[TBL] [Abstract][Full Text] [Related]
13. Early Termination of Oncology Clinical Trials in the United States.
Zhang E; DuBois SG
Cancer Med; 2023 Mar; 12(5):5517-5525. PubMed ID: 36305832
[TBL] [Abstract][Full Text] [Related]
14. Indications of Recruitment Challenges in Research with U.S. Military Service Members: A ClinicalTrials.gov Review.
Cook WA; Doorenbos AZ
Mil Med; 2017 Mar; 182(3):e1580-e1587. PubMed ID: 28290928
[TBL] [Abstract][Full Text] [Related]
15. Estimating the rate and reasons of clinical trial failure in urologic oncology.
Stensland KD; DePorto K; Ryan J; Kaffenberger S; Reinstatler LS; Galsky M; Canes D; Skolarus TA; Moinzadeh A
Urol Oncol; 2021 Mar; 39(3):154-160. PubMed ID: 33257221
[TBL] [Abstract][Full Text] [Related]
16. Early Termination of Acute Stroke Randomized Controlled Trials Published Between 2013 and 2020: A Systematic Review.
Strong B; Oostema JA; Nikroo N; Hussain M; Reeves MJ
Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007995. PubMed ID: 34932376
[TBL] [Abstract][Full Text] [Related]
17. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
Ohnmeiss DD
Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
[TBL] [Abstract][Full Text] [Related]
18. General characteristics and reasons for the discontinuation of drug clinical trials in mainland China.
Huo BN; Ai ML; Jia YT; Liu Y; Wang Y; Yin NG; Song L
BMC Med Res Methodol; 2021 Nov; 21(1):246. PubMed ID: 34773983
[TBL] [Abstract][Full Text] [Related]
19. Understanding the Termination of Urologic Cancer Clinical Trials: Insights and Challenges.
Alhajahjeh A; Hmeidan M; Elatrsh M; Al-Abbadi F; Kakish D; Sukerji R; Salah M; Al Awamlh BAH; Lee DI; Shahait M
JCO Glob Oncol; 2024 Jan; 10():e2300349. PubMed ID: 38207249
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]